About Aquyre Biosciences
Aquyre Biosciences is a private company based in Weston, Massachusetts. It has reported $28,589,402 raised in three offerings on Form D since October 2021. Its chief executive is Floyd Eberts, III.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 29, 2023 | Oct 23, 2023 | $3,220,502of $10.0M target | 2 | $1.6M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 25, 2022 | Mar 9, 2022amended May 27, 2022 | $5,423,710of $5.5M target | 3 | $1.8M | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Sep 29, 2021 | Oct 13, 2021 | $19,945,190of $37.9M target | 71 | $280K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $28,589,402 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aquyre Biosciences's Form D filed Oct 23, 2023.
CO
Cosme Ordonez
Director
FI
Floyd Eberts, III
President & Chief Executive Officer, director
RS
Ronald Sorenson
Director
CB
Claude Boccara
Executive officer
RM
Richard McCann
Executive officer
BP
Bertrand Le Conte Chrestien de Poly
Executive officer and director
GB
Gregory Bowles
Executive officer
FG
Francois Grammont
Executive officer
AF
Aurelio Fernandez
Director
Earlier filings also listed Thierry Thaure (executive officer and director, last listed May 2022), Ari Azhir (director, last listed May 2022), Aldo Maccari (director, last listed May 2022) and Michael Albin (director, last listed Oct 2021).